Boston- and Tel Aviv-based Converge Bio has raised $25 million in an oversubscribed Series A funding round to expand its generative AI platform for drug discovery.
Boston- and Tel Aviv-based Converge Bio has raised $25 million in an oversubscribed Series A funding round to expand its generative AI platform for drug discovery.
Ahead Health, a Zurich-based preventive healthcare startup, has secured $6 million in new funding to accelerate its expansion across Europe and further develop its early-detection health platform.
Dataroid, an Istanbul-based digital analytics and customer engagement company, has raised $6.6 million in a pre-Series A funding round to support international growth and product development.
Polar Light Technologies, a Linköping-based semiconductor company developing next-generation MicroLED displays, has secured more than €5 million in new funding to move closer to commercial deployment of its technology.
Deepgram has raised $130 million in a Series C funding round, valuing the company at $1.3 billion. The round was led by AVP and reflects growing demand for voice-based artificial intelligence across enterprise and consumer applications.
Nuclera, a Cambridge- and Boston-based biotechnology company focused on accelerating drug discovery through rapid access to functional proteins, has secured an additional $12 million in Series C funding.
NetBird, a Berlin-based company building an open-source alternative to traditional VPN and remote-access tools, has secured €8.5 million in Series A funding.
Klearly, an Amsterdam-based payments company built specifically for restaurants, bars, and clubs, has raised €12 million in a Series A funding round. The investment brings the company’s total capital raised to €20 million.
Homie, a Helsinki-based startup building a platform for relationship-driven B2B sales, has raised €1 million in pre-seed funding to support its market launch and international expansion.
